SG Americas Securities’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-19,915
| Closed | -$111K | – | 2952 |
|
2025
Q1 | $111K | Sell |
19,915
-46,449
| -70% | -$259K | ﹤0.01% | 2634 |
|
2024
Q4 | $536K | Sell |
66,364
-3,256
| -5% | -$26.3K | ﹤0.01% | 1102 |
|
2024
Q3 | $714K | Buy |
+69,620
| New | +$714K | ﹤0.01% | 1202 |
|
2023
Q3 | – | Sell |
-23,150
| Closed | -$180K | – | 2831 |
|
2023
Q2 | $180K | Buy |
+23,150
| New | +$180K | ﹤0.01% | 1606 |
|
2022
Q1 | – | Sell |
-13,650
| Closed | -$201K | – | 2870 |
|
2021
Q4 | $201K | Sell |
13,650
-11,585
| -46% | -$171K | ﹤0.01% | 2402 |
|
2021
Q3 | $528K | Buy |
+25,235
| New | +$528K | ﹤0.01% | 2247 |
|
2021
Q2 | – | Sell |
-5,695
| Closed | -$140K | – | 2752 |
|
2021
Q1 | $140K | Buy |
+5,695
| New | +$140K | ﹤0.01% | 2638 |
|
2020
Q4 | – | Sell |
-91,997
| Closed | -$2.3M | – | 2872 |
|
2020
Q3 | $2.3M | Buy |
91,997
+69,520
| +309% | +$1.74M | 0.01% | 529 |
|
2020
Q2 | $758K | Buy |
+22,477
| New | +$758K | 0.01% | 1432 |
|